GILD

Gilead Sciences (GILD) P/E Ratio
P/E Ratio as of Oct 30, 2026: -54.18
Average-56.10
Median-56.11
Minimum-59.74
Maximum-50.50
-54.18
2.77 (4.86%)past month
The P/E ratio for Gilead Sciences (GILD) is -54.18 as of Oct 30, 2026. This represents a decrease of -4,434.40% compared to its 12-month average P/E ratio of 1.25. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Gilead Sciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Gilead Sciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Gilead Sciences to industry peers.
Gilead Sciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Gilead Sciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Gilead Sciences to industry peers.
Gilead Sciences (GILD) P/E Ratio Insights
See Gilead Sciences’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Gilead Sciences (GILD)
Order type
Buy in
Order amount
Est. shares
0 shares
Gilead Sciences (GILD) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2026 | $147.50 | -55.53 |
| Sep 1, 2026 | $149.92 | -56.44 |
| Aug 3, 2026 | $131.15 | -49.37 |
| Jul 1, 2026 | $125.97 | 17.14 |
| Jun 1, 2026 | $131.10 | 17.84 |
| May 1, 2026 | $131.65 | 19.41 |
| Apr 1, 2026 | $140.30 | 20.69 |
| Mar 2, 2026 | $150.03 | 22.12 |
| Feb 2, 2026 | $142.89 | 22.13 |
| Jan 2, 2026 | $121.60 | 18.83 |
Gilead Sciences (GILD) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | -54.18 | -385.01% |
| 2025 | 19.01 | -98.17% |
| 2024 | 1041.38 | +5,895.28% |
| 2023 | 17.37 | -46.49% |
| 2022 | 32.46 | +120.67% |
| 2021 | 14.71 | — |
FAQs About Gilead Sciences (GILD) P/E ratio
The latest P/E ratio of Gilead Sciences (GILD) is -54.18, as of Oct 30, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Gilead Sciences’s last 12-month average P/E ratio is 1.25, compared to its current P/E ratio of -54.18. This reflects a decrease of -4,434.40%.
Gilead Sciences’s current P/E ratio of -54.18 is lower than its last 12-month average P/E of 1.25. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Gilead Sciences’s average P/E ratio over the last 3 years is 141.96. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Gilead Sciences’s average P/E ratio over the last 5 years is 92.69. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.
Gilead Sciences (GILD) P/E Ratio Insights
See Gilead Sciences’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Gilead Sciences (GILD)
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.